Board of Directors: Mark Enyedy - BioMarin Pharmaceutical Inc.
www.biomarin.com › company › mark-e...
Mark J. Enyedy has served on our Board since December 2023. Mr. Enyedy served as the President and Chief Executive Officer of ImmunoGen, Inc., a public biotechnology company, from May 2016 until February 2024, when ImmunoGen, Inc. was acquired by AbbVie Inc.
Experience: BioMarin Pharmaceutical Inc. · Education: Harvard Law School · Location: Lexington · 500+ connections on LinkedIn. View Mark Enyedy's profile on ...
Mark J. Enyedy
*/imgres?imgurl=https://www.biomarin.com/wp-content/uploads/2024/03/Mark-Enyedy_processed_800x525.jpg&imgrefurl=https://www.biomarin.com/company/board-of-directors/mark-enyedy/&h=525&w=800&tbnid=EUPBvhDw8J8xkM&q=Mark+J.+Enyedy&tbnh=94&tbnw=143&usg=AI4_-kTzitUzHzHH6_K5mWUeuS-gjpc-Jg&vet=1&docid=EYHGdeBgvNOKRM&hl=si&sa=X&ved=2ahUKEwi0reTrjeWIAxWdODQIHV0NNogQ9QF6BAgKEAQ)
*/imgres?imgurl=https://www.immunogen.com/wp-content/uploads/2018/04/MEnyedy_Square.jpg&imgrefurl=https://www.immunogen.com/who-we-are/executive-committee/&h=1024&w=1024&tbnid=vhPrY637A476BM&q=Mark+J.+Enyedy&tbnh=150&tbnw=150&usg=AI4_-kT5TkrkqyiG2_flog4qZxhNrAdHFg&vet=1&docid=jsq1Od1SdAGToM&hl=si&sa=X&ved=2ahUKEwi0reTrjeWIAxWdODQIHV0NNogQ9QF6BAgKEAY)
*/imgres?imgurl=https://cdn.theorg.com/fc142104-0f9c-4ed1-bed2-b8126fb84e78_thumb.jpg&imgrefurl=https://theorg.com/org/immunogen/org-chart/mark-enyedy&h=200&w=200&tbnid=P15tl4N3xssWdM&q=Mark+J.+Enyedy&tbnh=104&tbnw=104&usg=AI4_-kSZ-_6dQz21mI5PkLXn28nUvS_K3A&vet=1&docid=TFnAFeUUPpNWyM&hl=si&sa=X&ved=2ahUKEwi0reTrjeWIAxWdODQIHV0NNogQ9QF6BAgKEAo)
*/imgres?imgurl=https://invivo.citeline.com/-/media/editorial/headshots/corporate/e/enyedy_mark_1200.jpg?rev%3D1a6fc9f4b2b646b2b76095ca352ca200%26w%3D790%26hash%3D9A6D1929F71F97078D6AC3DD64662227&imgrefurl=http://invivo.citeline.com/IV005275/Deals-Driving-Oncology-ImmunoGen-CEO-Mark-Enyedy-on-Biopharmas-Year-Ahead&h=445&w=790&tbnid=luM1LDCbx9ZVgM&q=Mark+J.+Enyedy&tbnh=81&tbnw=143&usg=AI4_-kRuf6SNOs5e3HoiaokJHnm7FxqsRg&vet=1&docid=nvItLuSJq4_92M&hl=si&sa=X&ved=2ahUKEwi0reTrjeWIAxWdODQIHV0NNogQ9QF6BAgKEAw)
*/imgres?imgurl=https://i.ytimg.com/vi/mF6AFnngf4M/maxresdefault.jpg&imgrefurl=https://www.youtube.com/watch?v%3DmF6AFnngf4M&h=720&w=1280&tbnid=PiTRVSAGAv3MiM&q=Mark+J.+Enyedy&tbnh=84&tbnw=150&usg=AI4_-kSCYRs9oTUjEKibZY0nbdFA0h_TgA&vet=1&docid=eO0r4mP_0uHjEM&hl=si&sa=X&ved=2ahUKEwi0reTrjeWIAxWdODQIHV0NNogQ9QF6BAgKEA4)
Mark J. Enyedy. Mark J. Enyedy. Mr. Enyedy joined ImmunoGen in 2016 as President and CEO, bringing over twenty-five years of combined general management ...
Mark Joseph Enyedy is Former President/CEO at Immunogen Inc. See Mark Joseph Enyedy's compensation, career history, education, & memberships.
2024 මැයි 23 · Mark Enyedy is 56, he's been the President, Chief Executive Officer, and Director of Immunogen since 2016. There are 10 older and 6 younger ...
Mark Joseph Enyedy is currently the President & Chief Executive Officer at ImmunoGen, Inc. He is also an Independent Director at BioMarin Pharmaceutical, ...
The estimated net worth of Mark J Enyedy is at least $18 Million dollars as of 2024-09-25. Mark J Enyedy is the CHIEF EXECUTIVE OFFICER of Immunogen Inc and ...
2024 සැප් 8 · Mark J Enyedy has an estimated net worth of $37.2 Million. This is based on reported shares across multiple companies, which include ImmunoGen, ...
Company status: Active. Correspondence address: 830 Winter St., Waltham, Ma, 02451, United States. Role Resigned: Director. Appointed on: 3 November 2016.